@Mediciloninc
Discovery of Rapidly Adapting Antibody Opens Door for Universal Flu Vaccines | #flu Vaccines
Medicilon Assists ABM Therapeutics to Obtain US FDA Orphan Drug Qualification for ABM-1310 for the Treatment of Patients with Brain Glioblastoma Carrying BRAF V600 Mutation | #abm-1310